Form 4: KORU Medical Systems Director John Fletcher Reports Acquisition of Shares
SEC Form 4 Filing
John Fletcher, a director at KORU Medical Systems, reported acquiring 9,493 shares of common stock at $2.37 per share on March 31, 2024.
Summary
- On March 31, 2024, John Fletcher, a director at KORU Medical Systems, acquired 9,493 shares of common stock.
- The acquisition price was $2.37 per share.
- Following the transaction, Fletcher's beneficial ownership increased to 174,353 shares.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard disclosure of stock acquisition by a director. The purchase itself is a slightly positive signal, but the filing is primarily informational.
Positives
- A director's purchase of shares can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
This filing is a routine disclosure related to insider trading activity and provides transparency to the market regarding the transactions of company insiders.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/31/2024 | Date of transaction: Acquisition of common stock. |
| 04/01/2024 | Date of signature on the SEC Form 4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.